The aim of this study was to evaluate the relationship between IL-18 gene polymorphisms and susceptibility to chronic lymphocytic leukemias (CLL) and chronic myelogenous leukemias (CML) in Turkish patients. Here, IL18 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.